Safety and efficacy of targeted therapy for renal cell carcinoma (RCC) with brain metastasis.

被引：0
|
作者：
Bastos, Diogo Assed
Molina, Ana M.
Jia, Xiaoyu
Velasco, Susanne
Patil, Sujata
Voss, Martin Henner
Feldman, Darren Richard
Motzer, Robert John
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Biostat, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 04期
关键词：
D O I：
10.1200/jco.2014.32.4_suppl.497
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
497
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Safety and Efficacy of Targeted Therapy for Renal Cell Carcinoma With Brain Metastasis
    Bastos, Diogo A.
    Molina, Ana M.
    Hatzoglou, Vaios
    Jia, Xiaoyu
    Velasco, Susanne
    Patil, Sujata
    Voss, Martin H.
    Feldman, Darren R.
    Motzer, Robert J.
    CLINICAL GENITOURINARY CANCER, 2015, 13 (01) : 59 - 66
  • [2] Targeted therapy for renal cell carcinoma (RCC) with brain metastasis: Overall survival (OS) and safety.
    Bastos, Diogo Assed
    Molina, Ana M.
    Jia, Xiaoyu
    Velasco, Susanne
    Patil, Sujata
    Voss, Martin Henner
    Feldman, Darren Richard
    Motzer, Robert John
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] Combination targeted therapy in advanced renal cell carcinoma (RCC)
    Sosman, J.
    Puzanov, I.
    Atkins, M.
    Flaherty, K.
    ANNALS OF ONCOLOGY, 2008, 19 : 16 - 16
  • [4] SAFETY EVALUATION OF TARGETED THERAPIES IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (RCC)
    Leo, S.
    Chiuri, V. E.
    Accettura, C.
    Pellegrino, A.
    Giampaglia, M.
    Saracino, V
    Petrucelli, L.
    Lorusso, V
    ANNALS OF ONCOLOGY, 2009, 20
  • [5] Safety Evaluation of Targeted Therapies in Patients with Metastatic Renal Cell Carcinoma (RCC)
    Leo, S.
    Chiuri, V. E.
    Accettura, C.
    Pellegrino, A.
    Giampaglia, M.
    Saracino, V.
    Petrucelli, L.
    Lorusso, V.
    ONCOLOGY, 2009, 77 : 150 - 151
  • [6] Safety and clinical efficacy of everolimus in the treatment of advanced renal cell carcinoma (RCC)
    Shahani, Rohan
    Kwan, Kevin G.
    Kapoor, Anil
    DRUG HEALTHCARE AND PATIENT SAFETY, 2010, 2 : 85 - 91
  • [7] Efficacy and safety of AMG 102 in patients with advanced renal cell carcinoma (RCC)
    Kabbinavar, F.
    Garcia, J. A.
    Stadler, W. M.
    Gil, T.
    Jonasch, E.
    Tagawa, S. T.
    Smitt, M.
    Yang, X.
    Oliner, K.
    Schoffski, P.
    EJC SUPPLEMENTS, 2009, 7 (02): : 426 - 426
  • [8] COMPARATIVE EFFICACY AND SAFETY OF TARGETED THERAPY IN THE TREATMENT OF RENAL CELL CARCINOMA: A BAYESIAN NETWORK ANALYSIS
    Wei, W.
    Peng, R.
    Zeng, L.
    Xu, C.
    Cao, Y.
    Chen, W.
    Xia, S.
    VALUE IN HEALTH, 2018, 21 : S113 - S113
  • [9] Renal cell carcinoma marker (RCC-Ma) is specific for cutaneous metastasis of renal cell carcinoma
    Perna, Ashley G.
    Ostler, Daniel A.
    Ivan, Doina
    Lazar, Alexander J. F.
    Diwan, A. Hafeez
    Prieto, Victor G.
    Reed, Jon A.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2007, 34 (05) : 381 - 385
  • [10] Efficacy and safety of apatinib in osteosarcoma lung metastasis.
    Wang, Qianrong
    Wang, Xiaowen
    Wen, Lei
    Zhang, Jing
    Yang, Jingyue
    Chen, Yan
    Zhang, Hong-Mei
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345